MétaCan
Menu
Back to cohort
Record W4402786670 · doi:10.3389/fonc.2024.1478011

Editorial: Reviews in cancer metabolism: 2023

2024· editorial· en· W4402786670 on OpenAlexaff
Béla Ózsvári, Nadia Jacobo‐Herrera

Bibliographic record

VenueFrontiers in Oncology · 2024
Typeeditorial
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer, Lipids, and Metabolism
Canadian institutionsVancouver Biotech (Canada)
Fundersnot available
KeywordsCancerMedicineCancer researchBioinformaticsComputational biologyChemistryInternal medicineBiology

Abstract

fetched live from OpenAlex

Dysregulation of lipid metabolism has recently emerged as a hallmark of cancer (Beloribi-Djefaflia S), as well as alterations of the lipid profile in head and neck cancer. Liang J, et al describe in their review on lipid metabolism reprogramming and its potential therapeutic targets in head and neck cancer (Liang J). Figure 1 demonstrates the most important enzymes involved in lipid metabolism in head and neck cancer showing the elevated level of uptake and synthesis of various fatty acids and sterol lipids in cancer cells. 2 lists the potential lipid metabolism-related therapeutic targets, mostly overexpressed enzymes of different fatty acid synthases. They also highlighted the deteriorating effects of prolonged consumption of tobacco, alcohol, and high-fat diets on healthy cells.Non-small cell lung cancer (NSCLC) accounts for most lung cancer histological types, which mainly include squamous cell carcinoma and adenocarcinoma, and a poor survival rate. Wang Z, et al detail in their review about Aryl hydrocarbon receptor (AhR), which is a ligandactivated nuclear transcription factor. AhR overexpression helps tumor cells evade the immune system by sending inhibitory signals to the immune cells through the tumor microenvironment (Sadik A). Figure 1 highlights the clinical applications of metabolic reprogramming in tumors. In Figure 2, the authors revealed that AhR elevation correlates with increased glycolysis in cancer cells. In conclusion, they suggest that AhR is crucial in the regulation of cellular metabolism, especially in tumor metabolic reprogramming.Challenges in cancer treatment are metastasis, chemoresistance, and disease relapse; cancer stem cells (CSC) are known to be related to these phenomena. Wang and colleagues reviewed the impact of studying the cancer stem cells (CSCs) for cancer treatment (Wang H). CSCs can renew themselves, differentiate, and form new tumors, characteristics related to drug resistance, recurrence, and the spread of cancer cells to other parts of the body. Thus, targeting CSCs presents an opportunity for cancer treatment. They also delved into the changes observed in iron metabolism, lipid peroxidation, and the removal of lipid peroxides in CSCs, exploring their implications on ferroptosis. This research investigates the mechanisms governing iron metabolism and ferroptosis regulation in CSCs, extending the discussion to potential treatment tactics and new compounds that target CSCs by promoting ferroptosis.It is well-documented how tumors satisfy their energy, biosynthesis, and redox requirements by undergoing metabolic reprogramming, resulting in an increased lactate level and other metabolites in the tumor microenvironment. According to Xu and colleagues, lactate and lactylation mediate the reprogramming of immune cells and cellular adaptability to enhanced immunosuppression within the tumor microenvironment in hepatocellular carcinoma (HCC) (Xu Y). The alteration of glucose metabolism and the Warburg effect in HCC leads to significant lactate production and accumulation, suggesting abnormal lactate modification in tumor tissue. In this context, Xu reviewed the immune regulation of atypical lactate metabolism and lactate modification in hepatocellular carcinoma and the therapeutic approach of lactate-immunotherapy targeting, aiming to improve guidance for medication and treatment of patients with hepatocellular carcinoma.One of the main problems of monotherapies is chemoresistance. A strategy to target different hallmarks of the cancer cell simultaneously could be an appropriate approach to stop drug resistance, metastasis, and disease recurrence. In leukemia, despite the efforts in drug development, chemoresistance is still of concern with the current chemotherapies, reducing the success of a complete recuperation, especially in elderly patients. Feng, et al, introduced in their review the term "mitotherapy" and emphasized the importance of disordered mitochondrial metabolism and metabolic reprogramming as a therapeutic strategy in leukemia treatment, particularly in addressing chemoresistance (Feng L).In summary, the reviews within this special issue discussed some metabolic alterations observed in cancer cells, highlighting the significance of understanding cancer metabolism for developing targeted therapies and improving patient outcomes. Studies on lipid, iron, and lactate metabolism, and their roles in chemoresistance, as well as the exploration of mitochondria-dependent metabolic reprogramming in addressing chemoresistance, offer valuable insights into potential treatment strategies. By targeting specific metabolic pathways and identifying metabolic vulnerabilities, there is potential for innovative therapeutic approaches in cancer treatment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: Editorial
Teacher disagreement score0.065
Threshold uncertainty score0.217

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.010
Meta-epidemiology (narrow)0.0040.001
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0050.003
Science and technology studies0.0020.002
Scholarly communication0.0070.005
Open science0.0040.002
Research integrity0.0110.010
Insufficient payload (model declined to judge)0.0650.054

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.318
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in OncologySame topicCancer, Lipids, and MetabolismFrench-language works237,207